Search research articles
Contact Us
Filters
Showing results (31-40 of 112) with videos related to
Page
of 12
Sort By:
Journal of Neuro-Oncology
|
April 5, 2022
The posterior fossa syndrome questionnaire: using science to inform practice
Molly E Wickenhauser, Raja B Khan, Darcy Raches, et al.
Acta Neuropathologica
|
July 31, 2023
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
Quynh T Tran, Santhosh A Upadhyaya, Catherine A Billups, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
The New England Journal of Medicine
|
August 18, 2021
Lorlatinib in a Child with <i>ALK</i>-Fusion-Positive High-Grade Glioma
Aditi Bagchi, Brent A Orr, Olivia Campagne, et al.
Journal of Neuro-Oncology
|
November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors
Marie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Genes & Development
|
July 7, 2022
Primary cilia control translation and the cell cycle in medulloblastoma
Yong Ha Youn, Shirui Hou, Chang-Chih Wu, et al.
Journal of Neuro-Oncology
|
October 24, 2019
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis
Steven S Carey, Zsila Sadighi, Shengjie Wu, et al.
Nature Reviews. Cancer
|
November 24, 2012
Medulloblastomics: the end of the beginning
Paul A Northcott, David T W Jones, Marcel Kool, et al.
Neuro-Oncology Advances
|
April 29, 2024
[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas
Emily Y Kim, Amy L Vavere, Scott E Snyder, et al.
Brain Communications
|
March 6, 2025
MRI identifies disrupted cerebral development in medulloblastoma patients
Asim K Bag, Joseph Holtrop, John O Glass, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 112) with videos related to
Sort By:
Page
of 12
Journal of Neuro-Oncology
|
April 5, 2022
The posterior fossa syndrome questionnaire: using science to inform practice
Molly E Wickenhauser, Raja B Khan, Darcy Raches, et al.
Acta Neuropathologica
|
July 31, 2023
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
Quynh T Tran, Santhosh A Upadhyaya, Catherine A Billups, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
The New England Journal of Medicine
|
August 18, 2021
Lorlatinib in a Child with <i>ALK</i>-Fusion-Positive High-Grade Glioma
Aditi Bagchi, Brent A Orr, Olivia Campagne, et al.
Journal of Neuro-Oncology
|
November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors
Marie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Genes & Development
|
July 7, 2022
Primary cilia control translation and the cell cycle in medulloblastoma
Yong Ha Youn, Shirui Hou, Chang-Chih Wu, et al.
Journal of Neuro-Oncology
|
October 24, 2019
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis
Steven S Carey, Zsila Sadighi, Shengjie Wu, et al.
Nature Reviews. Cancer
|
November 24, 2012
Medulloblastomics: the end of the beginning
Paul A Northcott, David T W Jones, Marcel Kool, et al.
Neuro-Oncology Advances
|
April 29, 2024
[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas
Emily Y Kim, Amy L Vavere, Scott E Snyder, et al.
Brain Communications
|
March 6, 2025
MRI identifies disrupted cerebral development in medulloblastoma patients
Asim K Bag, Joseph Holtrop, John O Glass, et al.
Page
of 12